{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "51662-1545",
      "generic_name": "ROCURONIUM BROMIDE",
      "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst",
      "brand_name": "ROCURONIUM BROMIDE",
      "active_ingredients": [
        {
          "name": "ROCURONIUM BROMIDE",
          "strength": "100 mg/10mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "51662-1545-1",
          "description": "10 mL in 1 VIAL, MULTI-DOSE (51662-1545-1)",
          "marketing_start_date": "20220409",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "HF Acquisition Co LLC, DBA HealthFirst"
        ],
        "rxcui": [
          "1234995"
        ],
        "spl_set_id": [
          "dc444a4b-16ea-568d-e053-2995a90a53a7"
        ],
        "unii": [
          "I65MW4OFHZ"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "INJECTION, SOLUTION",
      "spl_id": "dc444a4b-16eb-568d-e053-2995a90a53a7",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "INTRAVENOUS"
      ],
      "marketing_start_date": "20220409",
      "product_id": "51662-1545_dc444a4b-16eb-568d-e053-2995a90a53a7",
      "application_number": "ANDA206206",
      "brand_name_base": "ROCURONIUM BROMIDE",
      "pharm_class": [
        "Neuromuscular Nondepolarizing Blockade [PE]",
        "Nondepolarizing Neuromuscular Blocker [EPC]"
      ]
    }
  ]
}